BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 28350328)

  • 1. Vitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled Trial.
    Irani M; Seifer DB; Grazi RV; Irani S; Rosenwaks Z; Tal R
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28350328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.
    Irani M; Seifer DB; Grazi RV; Julka N; Bhatt D; Kalgi B; Irani S; Tal O; Lambert-Messerlian G; Tal R
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4307-14. PubMed ID: 26485217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
    Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Razavi M; Jamilian M; Karamali M; Bahmani F; Aghadavod E; Asemi Z
    Horm Metab Res; 2016 Jul; 48(7):446-51. PubMed ID: 27050252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
    Foroozanfard F; Jamilian M; Bahmani F; Talaee R; Talaee N; Hashemi T; Nasri K; Asemi Z; Esmaillzadeh A
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):888-94. PubMed ID: 26119844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome.
    Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Talaee R; Jafarnejad S; Hashemi Dizaji S; Asemi Z
    J Affect Disord; 2018 Oct; 238():32-38. PubMed ID: 29859385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Nasri K; Akrami S; Rahimi M; Taghizadeh M; Behfar M; Mazandaranian MR; Kheiry A; Memarzadeh MR; Asemi Z
    Endocr Res; 2018 Feb; 43(1):1-10. PubMed ID: 28742409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
    Karadağ C; Yoldemir T; Yavuz DG
    J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
    Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
    Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Calcium, Vitamins D and K co-Supplementation on Markers of Insulin Metabolism and Lipid Profiles in Vitamin D-Deficient Women with Polycystic Ovary Syndrome.
    Karamali M; Ashrafi M; Razavi M; Jamilian M; Akbari M; Asemi Z
    Exp Clin Endocrinol Diabetes; 2017 May; 125(5):316-321. PubMed ID: 28407660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.
    Jamilian M; Foroozanfard F; Rahmani E; Talebi M; Bahmani F; Asemi Z
    Nutrients; 2017 Nov; 9(12):. PubMed ID: 29186759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
    Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
    Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR; Gargari BP; Farzadi L
    Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS.
    Irani M; Minkoff H; Seifer DB; Merhi Z
    J Clin Endocrinol Metab; 2014 May; 99(5):E886-90. PubMed ID: 24606102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Maktabi M; Chamani M; Asemi Z
    Horm Metab Res; 2017 Jul; 49(7):493-498. PubMed ID: 28679140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of vitamin D supplementation on lipid levels in polycystic ovary syndrome patients: a meta-analysis of randomized controlled trials.
    Jin B; Qian L; Fu X; Zhu J; Shu J
    J Int Med Res; 2020 Aug; 48(8):300060520935313. PubMed ID: 32776821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Maktabi M; Jamilian M; Asemi Z
    Biol Trace Elem Res; 2018 Mar; 182(1):21-28. PubMed ID: 28668998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
    Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
    J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in vitamin D receptor gene, but not vitamin D levels, are associated with polycystic ovary syndrome in Brazilian women.
    Xavier LB; Gontijo NA; Rodrigues KF; Cândido AL; Dos Reis FM; de Sousa MCR; Silveira JN; Oliveira Silva IF; Ferreira CN; Gomes KB
    Gynecol Endocrinol; 2019 Feb; 35(2):146-149. PubMed ID: 30182771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.